Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Dichloromethane | HCID 6344 | — |
| Reactant | Tetrahydrofuran | HCID 8028 | — |
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | Hydrazine | HCID 9321 | — |
| Solvent | 1,2-Dichloroethane | HCID 11 | — |
| Solvent | Acetone | HCID 180 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Solvent | Acetonitrile | HCID 6342 | — |
| Product | Hydrazine | HCID 9321 | — |
| Product | Diisopropylethylamine | HCID 81531 | — |
Reaction Steps
Alternatively, as also shown in Scheme VI, intermediate III-2 can be treated with hydrazine and an appropriate base such as triethylamine, diisopropylethylamine or excess hydrazine in a suitable organic solvent such as DCM, THF, DCE, acetone, DMF or acetonitrile to give intermediate VI-3. Intermediate VI-3 can then be treated with BrCN in the presence of a suitable base such as triethylamine, diisopropylethylamine, K2CO3, NaHCO3, or NaOAc in an appropriate organic solvent such as DCE, DCM, THF, ether, or acetonitrile at room temperature or elevated temperatures to give oxadiazole VI-4. Functionalization of the amino group affords oxadiazoles VI-5 (Arzneimittel-Forschung (2003), 53(5), 301-306; Heterocyclic Communications (2003), 9(2), 199-202; Arzneimittel-Forschung (2003), 53(1), 44-52).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08268871B2 |
|---|
| Source dataset | uspto-grants-2012_09 |
|---|
| ORD ID | ord-b25d3cebdf714864995abda3db739244 |
|---|
| Source note | uspto-grants-2012_09 |
|---|